Evidence status: CURRENT / DATED 2026. The practice currently hosts a 27-page new-patient packet containing a document titled 2026 Pain Contract. The same packet identifies Western Oklahoma Pain Specialists, doing business as Comprehensive Spine and Pain.

Quick read

The agreement requires a patient to initial and sign before receiving pain medication. It names the prescribing group, sets medication-use and monitoring rules, allows random pill counts and biological testing, ties noncompliance to taper/discontinuation or dismissal, adds appointment and treatment-plan compliance rules, and is followed by a separate 2026 code of conduct and urine-testing financial policy.

Who is on the provider side

The 2026 contract itself names the following clinicians as prescribing opioid pain medication and/or controlled substances for chronic pain management: Brian Blick, MD; Terrell Phillips, DO; David Sharrah, MD; Luke Mosel, DO; Richard Fair, MD; Michael Alvarado, MD; Madeleine Hill, PA; Jessica Kearney, APRN; Jessica Kennemer, APRN; and Brett Purvis, PA.

The practice’s current website identifies Brian E. Blick, MD as founder and owner of Comprehensive Spine and Pain and currently lists several of the clinicians named in the agreement on its team page. Where a person is named in the contract but is not independently confirmed on the current live roster, Seeds of Vice treats the contract itself as the evidence of that person’s role in this 2026 agreement and does not infer a broader current position.

What the patient agrees to

  • Take medication exactly as instructed and not alter dose or frequency without authorization.
  • Participate in the treatment plan and accept that medication continuation may depend on function, adverse effects, medical changes, and risk/benefit assessment.
  • Comply with medication monitoring, including random pill counts and urine, oral, blood, or hair testing when requested.
  • Respond to a requested random pill count within the timeframe stated by the practice; the packet specifies 24 hours.
  • Accept that inconsistent monitoring results, refusal to test, or other noncompliance can lead to medication taper/discontinuation and/or office dismissal.
  • Keep appointments and comply with treatment components such as injections, physical therapy, and referrals; specified patterns of missed/rescheduled visits may lead to dismissal.
  • Accept a separate urine-testing policy that states the practice conducts screening frequently and may charge the patient when insurance does not cover it.

Separate 2026 code-of-conduct provisions

The packet also contains a code of conduct with termination provisions not specific to Oklahoma opioid law. Among them, it says that yelling, cursing or disrespectful behavior may result in termination; threats or assaults result in termination; repeated no-shows/cancellations can result in termination; recording in clinic is prohibited; and social-media posts described by the form as slandering or speaking negatively about the clinic or providers are stated as grounds for termination.

Law versus clinic policy

Requirement Classification Why
Patient-provider agreement Required by law in specified circumstances Oklahoma law requires an agreement at the third opioid prescription and separately requires written agreement/informed-consent policies for qualifying opioid-therapy patients.
Signing before any pain medication Clinic policy / potentially earlier than statutory trigger The statute creates minimum triggers; the 2026 packet states the practice requires initials/signature before receiving pain medication.
Random pill counts and biological testing Discretionary monitoring within a statutorily recognized category Oklahoma’s agreement definition permits monitoring measures including specimen screens and pill counts; it does not make this exact cadence or consequence universal.
24-hour pill-count response Clinic-specific policy No universal Oklahoma 24-hour response rule was identified in the governing agreement statutes.
Dismissal for missed visits / treatment-plan noncompliance Clinic-specific policy Oklahoma law requires an agreement to describe termination and consequences, but does not supply these particular triggers.
Urine-testing cost shifted to patient if insurance does not pay Clinic financial policy The packet states this expressly; it is not classified as a statewide opioid-agreement mandate.
Social-media / recording provisions Clinic code-of-conduct policy These terms are not identified as Oklahoma statutory opioid-agreement requirements.

Why this document is particularly useful evidence

This is one of the strongest Oklahoma examples because the document is dated 2026, comes from the practice’s own current website, names the prescribing side, and bundles the medication agreement with related termination, monitoring, and payment provisions. That makes it possible to distinguish the legal agreement requirement from additional office conditions imposed alongside it.

Primary sources

← Oklahoma Contract-for-Care Evidence Library

Reviewed: October 4, 2026.

Evidence boundary: This page describes what the public 2026 packet says and compares the document to identified Oklahoma authority. It does not determine enforceability of a particular clause, whether a clause was applied to a particular patient, or why the practice adopted it.